Product details


OZURDEX® is an intravitreal implant containing 0.7 mg (700 μg) dexamethasone in the NOVADUR™ solid polymer drug delivery system. OZURDEX® is preloaded into a single-use, specially designed DDS® applicator to facilitate injection of the rod-shaped implant directly into the vitreous. The NOVADUR™ system contains poly (D,L - lactide-co-glycolide) PLGA intravitreal polymer matrix. OZURDEX® is preservative-free.
With Prescription
  • Group


  • Dosage And Administration

    For ophthalmic intravitreal injection only.

    The intravitreal injection procedure should be carried out under controlled aseptic conditions. Following the intravitreal injection, patients should be monitored for elevation in intraocular pressure and for endophthalmitis.

  • Each mL contains

    OZURDEX® contains a corticosteroid indicated for the treatment of macular edema following branch retinal vein occlusion (BRVO) or central retinal vein occlusion (CRVO).

  • Active Ingredient

    Dexamethasone Intravitreal Implant

  • How supplied

    OZURDEX® (dexamethasone intravitreal implant) 0.7 mg is supplied in a foil pouch with 1 single-use plastic applicator.